Canine leptospirosis: A re-emerging disease in the United States (Proceedings) - Veterinary Healthcare


Canine leptospirosis: A re-emerging disease in the United States (Proceedings)



1. Ward MP, Glickman LT, Guptill L. Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970-1998). JAVMA. 2002;220:53-58.

2. Ward MP, Guptill LF, Prahl A, Wu C-C. Serovar-specific prevalence and risk factors for leptospirosis among dogs: 90 cases (1997-2002). JAVMA. 2004;224:1958-1963.

3. Harkin KR, Gartrell CL. Canine leptospirosis in New Jersey and Michigan: 17 cases (1990-1995). JAAHA. 1996;32:495-501.

4. Birnbaum N, Barr SC, Center SA, Schermerhorn T, Randolph JF, Simpson KW. Naturally acquired leptospirosis in 36 dogs: serological and clinicopathological features. J Small Anim Pract. 1998;39:231-236.

5. Adin CA, Cowgill LD. Treatment and outcome of dogs with leptospirosis: 36 cases (1990-1998). JAVMA. 2000;216:371-375.

6. Stokes JE, Kaneene JB, Schall WD, et al. Prevalence of serum antibodies against six Leptospira serovars in healthy dogs. JAVMA. 2007;230:1657-1664.

7. Prescott JF, McEwen B, Taylor J, Wookds JP, Abrams-Ogg A, Wilcock B. Resurgence of leptospirosis in dogs in Ontario: recent findings. Can Vet J. 2002;43:955-961.

8. Moore GE, Guptill LF, Glickman NW, Caldanaro RJ, Aucoin D, Glickman LT. Canine leptospirosis, United States, 2002-2004. Emerg Infect Dis. 2006;12:501-503.

9. Sessions JK, Greene CE. Canine leptospirosis: Epidemiology, pathogenesis, and diagnosis. Compend Contin Educ Pract Vet. 2004;26:606-623.

10. Langston CE, Heuter KJ. Leptospirosis— A re-emerging zoonotic disease. Vet Clin North Am Small Anim Pract. 2003;33:791-807.

11. Ward MP. Seasonality of canine leptospirosis in the United States and Canada and its association with rainfall. Prev Vet Med. 2002;56:203-213.

12. Kim HW, Chew BP, Wong TS, et al. Dietary lutein stimulates immune response in the canine. Vet Immunol Immunopathol. 2000;74:315-327.

13. Ghneim GS, Viers JH, Chomel BB, Kass PH, Descollongs DA, Johnson ML. Use of a case-control study and geographic information systems to determine environmental and demographic risk factors for canine leptospirosis. Vet Res. 2007;38:37-50.

14. Ward MP, Guptill LF, Wu C-C. Evaluation of environmental risk factors for leptospirosis in dogs: 36 cases (1997-2002). JAVMA. 2004;225:72-77.

15. Goldstein RE, Lin RC, Langston CE, Scrivani PV, Erb HA, Barr SC. Influence of infecting serogroup on clinical features of leptospirosis in dogs. J Vet Intern Med. 2006;20:489-494.

16. Wohl JS. Canine leptospirosis. Compend Contin Educ Pract Vet. 1996;18:1215-1225.

17. Bolin CA. Diagnosis of leptospirosis: A reemerging disease of companion animals. Semin Vet Med Surg. 1996;11:166-171.

18. Ribotta MJ, Fortin M, Higgins R. Canine leptospirosis: Serology. Can Vet J. 2000;41:494-495.

19. Harkin KR, Roshto YM, Sullivan JT. Clinical application of a polymerase chain reaction assay for diagnosis of leptospirosis in dogs. JAVMA. 2003;222:1224-1229.

20. Sessions JK, Greene C. Canine leptospirosis: treatment, prevention, and zoonosis. Comp Contin Educ Pract Vet. 2004;26:700-706.

21. Truccolo J, Charavay F, Merien F, Perolat P. Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother. 2002;46:848-853.

22. Barr SC, McDonough PL, Scipioni-Ball RL, Starr JK. Serologic responses of dogs given a commercial vaccine against Leptospira interrogans serovar pomona and Leptospira kirschneria serovar grippotyphosa. Am J Vet Res. 2005;66:1780-1784.

23. Brown K, Prescott JF. Leptospirosis in the family dog: a public health perspective. CMAJ. 2008;178:397-398.


Click here